MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, TARS made $162,054K in revenue. -$7,646K in net income. Net profit margin of -4.72%.

Income Overview

Revenue
$162,054K
Net Income
-$7,646K
Net Profit Margin
-4.72%
EPS
-$0.16
Unit: Thousand (K) dollars
Revenue Breakdown
    • Product
    • License And Collaboration

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Total revenues
162,054 151,668 118,697 102,660
Cost of sales-Product
-5,757* --
Research and development
-18,283* --
Selling, general and administrative
-135,605* --
Total operating expenses
168,176 159,644 133,226 124,844
Loss from operations before other income (expense)
-6,122 -7,976 -14,529 -22,184
Interest income
3,722 3,950 4,114 4,229
Interest expense
2,128 2,214 2,268 2,240
Loss on debt extinguishment
-0 0 0
Other income (expense), net
-87 -74 98 -145
Total other income (expense), net
1,507 1,662 1,944 1,844
Loss before income taxes
--7,858* --
Provision for income taxes
2,352 515* --
Net loss
-6,967 -8,373 -12,585 -20,340
Unrealized gain (loss) on marketable securities and cash equivalents
-679 92 250 -46
Comprehensive loss
-7,646 -8,281 -12,335 -20,386
Basic EPS
-0.16 -0.193 -0.3 -0.48
Diluted EPS
-0.16 -0.193 -0.3 -0.48
Basic Average Shares
42,956,973 42,822,528 42,607,717 42,360,452
Diluted Average Shares
42,956,973 42,822,528 42,607,717 42,360,452
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Comprehensive loss-$7,646K (69.68%↑ Y/Y)Interest income$3,722K (7.76%↑ Y/Y)Net loss-$6,967K (72.27%↑ Y/Y)Unrealized gain (loss) onmarketable securities and...-$679K (-622.34%↓ Y/Y)Total other income(expense), net$1,507K (29.91%↑ Y/Y)Product$145,387K License AndCollaboration$16,667K Interest expense$2,128K (-3.84%↓ Y/Y)Other income(expense), net-$87K (-7.41%↓ Y/Y)Loss from operationsbefore other income...-$6,122K (76.70%↑ Y/Y)Provision for income taxes$2,352K Total revenues$162,054K (106.87%↑ Y/Y)Total operatingexpenses$168,176K (60.76%↑ Y/Y)

Tarsus Pharmaceuticals, Inc. (TARS)

Tarsus Pharmaceuticals, Inc. (TARS)